is applicable to variant alkylarylethers such as eugenol, vanillin, ortho-vanillin and methyl eugenol. Suitable substrates are not limited to alkyl o-hydroxyphenyl ethers. A practical procedure for the cleavage of alkylarylethers containing labile functional groups has been developed using aluminum triiodide as the ether cleaving reagent. Carbodiimides, typically used as dehydration reagents for
Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds
作者:Srinivas Jada、Mahendhar Reddy Doma、Parvinder Pal Singh、Suresh Kumar、Fayaz Malik、Akash Sharma、Inshad Ali Khan、G.N. Qazi、H.M. Sampath Kumar
DOI:10.1016/j.ejmech.2011.12.039
日期:2012.5
A series of novel magnolol derivatives were synthesised and evaluated for in vitro antimicrobial and antiproliferative activities. We found that most of the compounds were effective inhibitors of Staphylococcus aureus, MRSA and VRE with MIC in the range of 1-64 mu g/mL and MBC in the range of 1-128 mu g/mL. Few derivatives also exhibited promising antifungal activity. Some magnolol analogues exhibited promising antiproliferative activity than parent magnolol when tested against three human cancer cell lines. (C) 2012 Elsevier Masson SAS. All rights reserved.
Chemoenzymatic Synthesis and α-Glucosidase Inhibitory Activity of Dimeric Neolignans Inspired by Magnolol
A chemoenzymatic synthesis of a small library of dimeric neolignans inspired by magnolol (1) is reported. The 2-iodoxybenzoic acid (IBX)-mediated regioselective orthohydroxylation of magnolol is described, affording the bisphenols 6 and 7. Further magnolol analogues (12, 13, 15-17, 19-23) were obtained from eugenol (3), tyrosol (4), and homovanillic alcohol (5), through horseradish peroxidase (HRP)-mediated oxidative coupling and regioselective orthohydroxylation or ortho-demethylation in the presence of MX, followed by reductive treatment with Na2S2O4. A chemoselective protection/deprotection of the alcoholic group of 4 and 5 was carried out by lipase-mediated acetylation/deacetylation. The dimeric neolignans, together with 1 and honokiol (2), were evaluated as inhibitors of yeast a-glucosidase, in view of their possible utilization and optimization as antidiabetic drugs. The synthetic analogues of magnolol showed a strong inhibitory activity with IC50 values in the range 0.15-4.1 mu M, much lower than those of honokiol and the reference compounds quercetin and acarbose. In particular, a very potent inhibitory activity, with an IC50 of 0.15 mu M, was observed for 1,1'-dityrosol-8,8'-diacetate (15), and comparable inhibitory activities were also shown by bisphenols 6 (0.49 mu M), 13 (0.50 mu M), and 22 (0.86 mu M). A kinetic study showed that 15 acts as a competitive inhibitor, with a K-i value of 0.86 mu M.
Cytotoxic neolignans: an SAR study
作者:Zwe-Ling Kong、Shin-Cheng Tzeng、Yeuk-Chuen Liu
DOI:10.1016/j.bmcl.2004.10.011
日期:2005.1
The neolignans, magnolol 1 and honokiol 2 have been reported to inhibit the growth of several tumor cell lines in vitro and in vivo. The chemical structure of magnolol and honokiol consists of biphenyl skeleton with phenolic and allylic functionalities. Analogs of 1 and 2 containing different substitution have been studies for their effect on the growth of Hep-G2 and their structure-activity relationships were reported in this work. (C) 2004 Elsevier Ltd. All rights reserved.